AbCellera
ShareCopied to clipboardAbCellera is a company. It is a public company in Vancouver, Canada. It was founded in 2012 and its current CEO is Carl L.G. Hansen. It is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Vancouver
- country: Canada
- employees: 596 people
- revenues: 33M $
- company type: public
- sector: Health Care
- industry: Biotechnology
- foundation year: 2012
- CEO: Carl L.G. Hansen
- ESG score: 67.98 / 100
See more facts
Extract data
Download datasets about AbCellera:
Dataset of stocks from AbCellera:
AbCellera is one of the companies in Canada, companies in Biotechnology, companies in Health Care, companies in Vancouver and 3,456,808 companies in our database.
Talking Points
- AbCellera is an antibody discovery and development engine specifically designed to break the barriers of conventional discovery and help bring new medicines to patients sooner.
- A tech company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed into drugs to prevent and treat disease.
- Full-stack, AI-powered antibody discovery | AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. Its full-stack, AI-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell ...
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.